Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicolas Gestermann
LAG-3 and PD-1+LAG-3 Inhibition Promote Anti-Tumor Immune Responses in Human Autologous Melanoma/T Cell Co-Cultures
OncoImmunology
Oncology
Allergy
Immunology
Netting Neutrophils Activate Autoreactive B Cells in Lupus
Journal of Immunology
Allergy
Immunology
Related publications
Expression of LAG-3 and Efficacy of Combination Treatment With Anti-Lag-3 and Anti-Pd-1 Monoclonal Antibodies in Glioblastoma
International Journal of Cancer
Cancer Research
Oncology
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells
Frontiers in Immunology
Allergy
Immunology
Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-Receptor LAG-3 for Enhanced Anti-Tumor Immunity
Cell Reports
Biochemistry
Genetics
Molecular Biology
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Journal of Immunology
Allergy
Immunology
Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma
New England Journal of Medicine
Medicine
Biochemical Analysis of the Regulatory T Cell Protein Lymphocyte Activation Gene-3 (LAG-3; CD223)
Journal of Immunology
Allergy
Immunology
Fibrinogen-Like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Cell
Biochemistry
Genetics
Molecular Biology
Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
PLoS ONE
Multidisciplinary
CD 4 + CD 25 − LAG 3 + Regulatory T Cells in Humoral Immunity
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology